Campbell & Co Investment Adviser’s Usana Health Sciences USNA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,158	Closed	-$371K	–	1397
2025 Q2	$371K	Sell	12,158 -359	-3%	-$10.2K	0.02%	891
2025 Q1	$338K	Buy	12,517 +4,109	+49%	+$130K	0.03%	821
2024 Q4	$302K	Buy	+8,408	New	+$314K	0.02%	849
2024 Q3	–	Sell	-6,170	Closed	-$279K	–	1352
2024 Q2	$279K	Buy	+6,170	New	+$284K	0.02%	850
2022 Q3	–	Sell	-3,422	Closed	-$248K	–	950
2022 Q2	$248K	Sell	3,422 -7,288	-68%	-$543K	0.07%	531
2022 Q1	$851K	Buy	+10,710	New	+$966K	0.23%	111
2020 Q3	–	Sell	-3,503	Closed	-$257K	–	483
2020 Q2	$257K	Buy	+3,503	New	+$275K	0.33%	136
2019 Q2	–	Sell	-2,514	Closed	-$211K	–	716
2019 Q1	$211K	Buy	+2,514	New	+$262K	0.1%	424
2018 Q3	–	Sell	-3,000	Closed	-$346K	–	533
2018 Q2	$346K	Buy	+3,000	New	+$328K	0.27%	148
2015 Q1	–	Sell	-7,548	Closed	-$387K	–	287
2014 Q4	$387K	Buy	+7,548	New	+$371K	0.24%	140

Other funds holding USNA

SWGC

Summit Wealth Group (Colorado) Colorado Springs, Colorado $950M AUM 24.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Campbell & Co Investment Adviser's USNA Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Usana Health Sciences (USNA) in Q3 2025, closing a stake of 12,158 shares — an estimated $371K sold.

Campbell & Co Investment Adviser first reported a position in USNA in Q4 2014 and held it in 10 quarters. The position peaked at $851K in Q1 2022. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.

Campbell & Co Investment Adviser reported no remaining Usana Health Sciences position as of Q3 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 12,158 Usana Health Sciences shares in Q3 2025, an estimated $371K.
Campbell & Co Investment Adviser first reported a position in Usana Health Sciences in Q4 2014 and held it in 10 quarters.
Campbell & Co Investment Adviser's Usana Health Sciences position peaked at $851K in Q1 2022.
165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.